OBJECTIVE: Research and clinical translation in schizophrenia is limited by inconsistent definitions of treatment resistance and response. To address this issue, the authors evaluated current approaches and then developed consensus criteria and guidelines. METHOD: A systematic review of randomized antipsychotic clinical trials in treatment-resistant schizophrenia was performed, and definitions of treatment resistance were extracted. Subsequently, consensus operationalized criteria were developed through 1) a multiphase, mixed methods approach, 2) identification of key criteria via an online survey, and 3) meetings to achieve consensus. RESULTS: Of 2,808 studies identified, 42 met inclusion criteria. Of these, 21 studies (50%) did not provid...
Despite pharmacological advances in the treatment of schizophrenia, significant number of patients c...
Background: Roughly 30% of schizophrenia patients fail to respond to at least two antipsychotic tria...
Abstract Background: As the burden of treatment-resistant schizophrenia (TRS) on patients and socie...
Objective: Research and clinical translation in schizophrenia is limited by inconsistent definitions...
© Copyright 2019 Physicians Postgraduate Press, Inc. Treatment-resistant schizophrenia (TRS) occurs ...
Treatment-resistant schizophrenia, also known as refractory schizophrenia, is a severe and debilitat...
ABSTRACT: Purpose: To discuss the importance of 1). Closely monitoring antipsychotic treatment and 2...
Treatment-resistant schizophrenia (TRS) is most defined as an inadequate response in schizophrenia s...
INTRODUCTION: Schizophrenia is a debilitating condition with three main symptom domains: positive, n...
Large-scale pharmacoepidemiological research on treatment resistance relies on accurate identificati...
Novel treatment modalities, such as non-invasive brain stimulation (NIBS), typically focus on patien...
Although approximately 1/3 of individuals with schizophrenia are Treatment Resistant (TR), identifyi...
Background: Schizophrenia is a highly heterogeneous disorder, and around a third of patients are tre...
Background: Roughly 30% of schizophrenia patients fail to respond to at least two antipsychotic tria...
Treatment-resistant schizophrenia is a lack of adequate response to antipsychotic medications result...
Despite pharmacological advances in the treatment of schizophrenia, significant number of patients c...
Background: Roughly 30% of schizophrenia patients fail to respond to at least two antipsychotic tria...
Abstract Background: As the burden of treatment-resistant schizophrenia (TRS) on patients and socie...
Objective: Research and clinical translation in schizophrenia is limited by inconsistent definitions...
© Copyright 2019 Physicians Postgraduate Press, Inc. Treatment-resistant schizophrenia (TRS) occurs ...
Treatment-resistant schizophrenia, also known as refractory schizophrenia, is a severe and debilitat...
ABSTRACT: Purpose: To discuss the importance of 1). Closely monitoring antipsychotic treatment and 2...
Treatment-resistant schizophrenia (TRS) is most defined as an inadequate response in schizophrenia s...
INTRODUCTION: Schizophrenia is a debilitating condition with three main symptom domains: positive, n...
Large-scale pharmacoepidemiological research on treatment resistance relies on accurate identificati...
Novel treatment modalities, such as non-invasive brain stimulation (NIBS), typically focus on patien...
Although approximately 1/3 of individuals with schizophrenia are Treatment Resistant (TR), identifyi...
Background: Schizophrenia is a highly heterogeneous disorder, and around a third of patients are tre...
Background: Roughly 30% of schizophrenia patients fail to respond to at least two antipsychotic tria...
Treatment-resistant schizophrenia is a lack of adequate response to antipsychotic medications result...
Despite pharmacological advances in the treatment of schizophrenia, significant number of patients c...
Background: Roughly 30% of schizophrenia patients fail to respond to at least two antipsychotic tria...
Abstract Background: As the burden of treatment-resistant schizophrenia (TRS) on patients and socie...